Afectación pericárdica en enfermedades de patogenia inmunológica, infecciosa y endocrinológicas

  1. Balaguer Recena, J.
  2. Tarancón Zubimendi, B.
  3. Novo García, Enrique
  4. García Ortego, S.
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Ano de publicación: 2013

Título do exemplar: Enfermedades cardiovasculares (IX): pericarditis

Serie: 11

Número: 43

Páxinas: 2583-2590

Tipo: Artigo

DOI: 10.1016/S0304-5412(13)70665-6 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Medicine: Programa de Formación Médica Continuada Acreditado

Obxectivos de Desenvolvemento Sustentable

Resumo

La patología del pericardio muestra múltiples etiologías, existen gran número de enfermedades sistémicas que afectan al mismo. Se pueden clasificar en tres grandes grupos: enfermedades autoinmunes, enfermedades neoplásicas y enfermedades metabólicas. En las enfermedades metabólicas se debe distinguir la secundaria a la insuficiencia renal y las enfermedades endocrinas. La insuficiencia renal es una causa frecuente de patología pericárdica, incluso en los pacientes con diálisis. Entre las enfermedades endocrinas, el mixedema es la causa más frecuente. Las enfermedades autoinmunes representan un grupo muy importante a tener en cuenta en el diagnóstico de estas patologías. Por último, los procesos neoplásicos, sobre todo el cáncer de pulmón y de mama, representan las causas más frecuentes.

Referencias bibliográficas

  • Abraham KP, Reddy V, Gattuso P. Neoplasms metastatic to the heart: review of 3314 consecutive autopsies. Am J Cardiovasc Pathol. 1990;3:195.
  • Agard C, Rendu E, Leguern V, Ponge T, Masseau A, Barrier JH. Churg-Strauss syndrome revealed by granulomatous acute pericarditis: two case reports and a review of the literature. Semin Arthritis Rheum. 2007;36:386.
  • Atzeni F, Sarzi-Puttini P, Doria A, Boiardi L, Pipitone N, Salvarani C. Behçet’s disease and cardiovascular involvement. Lupus. 2005;14:723.
  • Baldini C, Talarico R, Della Rossa A, Bombardieri S. Clinical manifestations and treatment of Churg-Strauss syndrome. Rheum Dis Clin North Am. 2010;36:527.
  • Barbaric D, Holley D, Lau KC, McCowage G. It is ALL in the heart: a patient with acute lymphoblastic leukemia and cardiac infiltration at time of diagnosis. Leuk Lymphoma. 2002;43:2417.
  • Bazzani C, Cavazzana I, Ceribelli A, Vizzardi E, Dei Cas L, Franceschini F. Cardiological features in idiopathic inflammatory myopathies. J Cardiovasc Med (Hagerstown). 2010;11:906.
  • Ben-Horin S, Bank I, Guetta V, Livneh A. Large symptomatic pericardial effusion as the presentation of unrecognized cancer: a study in 173 consecutive patients undergoing pericardiocentesis. Medicine (Baltimore). 2006;85:49.
  • Byers RJ, Marshall DA, Freemont AJ. Pericardial involvement in systemic sclerosis. Ann Rheum Dis. 1997;56:393.
  • Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Bellisai F, Rossi Paccani S. Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor associated periodic syndrome. Int J Immunopathol Pharmacol. 2009;22:1051.
  • Cantarini L, Lucherini OM, Baldari CT, Laghi Pasini F, Galeazzi M. Familial clustering of recurrent pericarditis may disclose tumour necrosis actor receptor associated periodic syndrome. Clin Exp Rheumatol. 2010;28:405.
  • Chen Y, Brennessel D, Walters J, Johnson M, Rosner F, Raza M. Human immunodeficiency virus associated pericardial effusion: report of 40 cases and review of the literature. Am Heart J. 1999;137:516.
  • Colombo A, Olson HG, Egan J, Gardin JM. Etiology and prognostic implications of a large pericardial effusion in men. Clin Car-diol. 1988;11:389.
  • Connors JP, Kleiger RE, Shaw RC, Voiles JD, Clark RE, Harter H. The indications for pericardiectomy in the uremic pericardial effusion. Surgery. 1976;80(6):689-94.
  • Cullen S, Duff DF, Denham B, Ward OC. Cardiovascular manifestations in Kawasaki disease. Ir J Med Sci. 1989;158:253.
  • Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus. 2005;14:683.
  • Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still’s disease. Ann Rheum Dis. 2006;65:564.
  • Gornik HL, Gerhard-Herman M, Beckman JA. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol. 2005;23:5211.
  • Gouny P, Lancelin C, Girard PM, Hocquet-Cheynel C, Rozenbaum W, Nussaume O. Pericardial effusion and AIDS: benefits of surgical drain-age. Eur J Cardiothorac Surg. 1998;13:165.
  • Guillaume M, Vachiery F, Cogan E. Pericarditis: an unusual manifestation of giant cell arteritis. Am J Med. 1991;91:662.
  • Gunukula SR, Spodick DH. Pericardial disease in renal patients. Semin Nephrol. 2001;21:52-7.
  • Gyöngyösi M, Pokorny G, Jambrik Z, Kovács L, Kovács A, Makula E. Cardiac manifestations in primary Sjögren’s syndrome. Ann Rheum Dis. 1996;55:450.
  • Hardisty CA, Naik RD, Munro DS. Pericardial effusion in hypothyroidism. Clin Endocrinol. 1980;13:349-54.
  • Imazio M, Brucato A, Trinchero R, Spodick D, Adler Y. Colchicine for pericarditis: hype or hope? Eur Heart J. 2009;30:532.04
  • Kees S, Langevitz P, Zemer D, Padeh S, Pras M, Livneh A. Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF). QJM. 1997;90:643.
  • Kerber RE, Sherman B. Echocardiographic evaluation of pericardial effusion in myxedema. Incidence and biochemical and clinical correlations. Circulation. 1975;52:823-7.
  • Klatt EC, Heitz DR. Cardiac metastases. Cancer. 1990;65:1456.
  • Knockaert DC. Cardiac involvement in systemic inflammatory diseases. Eur Heart J 2007; 28:1797.
  • Laham RJ, Cohen DJ, Kuntz RE, Baim DS, Lorell BH, Simons M. Pericardial effusion in patients with cancer: outcome with contemporary management strategies. Heart. 1996;75:67.
  • Lam KY, Dickens P, Chan AC. Tumors of the heart. A 20 year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med. 1993;117:1027.
  • Li JJ, Fang CH, Chen MZ, Chen X. Takayasu’s arteritis accompanied with pericarditis: a case report. Cardiology. 2004;102:106.
  • Lundberg IE. Cardiac involvement in autoimmune myositis and mixed connective tissue disease. Lupus. 2005;14:708.
  • Lundin AP. Recurrent uremic pericarditis: a marker of inadequate dialysis. Semin Dial. 1990;3:5-9.
  • Lundin AP. Recurrent uremic pericarditis: a marker of inadequate dialysis. Semin Dial. 1990;3:5-9.
  • MacGee W. Metastatic and invasive tumours involving the heart in a geriatric population: a necropsy study. Virchows Arch A Pathol Anat Histopathol. 1991;419:183.
  • Maisch B, Ristic A, Pankuweit S. Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis. 2010;53:157.
  • Maisch B, Ristic AD. The classification of pericardial disease in the age of modern medicine. Curr Cardiol Rep. 2002;4(1):13-21.
  • Mann T, Brodie BR, Grossman W, McLaurin L. Effusive constrictive hemodynamic pattern due to neoplastic involvement of the pericardium. Am J Cardiol. 1978;41:781.
  • McDonald JM, Meyers BF, Guthrie TJ, Battafarano RJ, Cooper JD, Patterson GA. Comparison of open subxiphoid pericardial drainage with percutaneous catheter drainage for symptomatic pericardial effusion. Ann Thorac Surg. 2003;76:811.
  • Meune C, Vignaux O, Kahan A, Allanore Y. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Arch Cardiovasc Dis. 2010;103:46.
  • Narita H, Ohte N, Yoneyama A, Hashimoto T, Akita S, Sakuma N. Takayasu’s arteritis accompanied with massive pericardial effusion: a case report. Angiology. 1999;50:421.
  • Okutur K, Seber S, Oztekin E, Bes C, Borlu F. Recurrent pericarditis as the initial manifestation of Familial Mediterranean fever. Med Sci Monit. 2008;14:CS139.
  • Parvez N, Carpenter JL. Cardiac tamponade in Still disease: a review of the literature. South Med J. 2009;102:832.
  • Parving HH, Hansen JM, Nielsen SV, Rossing N, Munck O, Lassen NA. Mechanism of edema formation in myxedema increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med. 1979;(30)301:460-5.
  • Picco P, Brisca G, Traverso F, Loy A, Gattorno M, Martini A. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease? Arthritis Rheum. 2009;60:264.
  • Porte HL, Janecki-Delebecq TJ, Finzi L, Métois DG, Millaire A, Wurtz AJ. Pericardoscopy for primary management of pericardial effusion in cancer patients. Eur J Cardiothorac Surg. 1999;16:287.
  • Rigante D, Cantarini L, Imazio M, Lucherini OM, Sacco E, Galeazzi M. Autoinflammatory diseases and cardiovascular manifestations. Ann Med. 2011;43:341.
  • Rostand SG, Rutsky EA. Pericarditis in end stage renal disease. Cardiol Clin. 1990;8:701-6.
  • Rutsky EA. Treatment of uremic pericarditis and pericardial effusion. Am J Kidney Dis. 1987;10:2-7.
  • Sampat K, Rossi A, García-Gutiérrez V, Cortes J, Pierce S, Kantarjian H. Characteristics of pericardial effusions in patients with leukemia. Cancer. 2010;116:2366.
  • Scardapane A, Brucato A, Chiarelli F, Breda L. Efficacy of an Interleukin-1β receptor antagonist (Anakinra) in idiopathic recurrent pericarditis. Pediatr Cardiol. En prensa 2012.
  • Spector D, Alfred H, Siedlecki M, Briefel G. A controlled study of the effect of indomethacin in uremic pericarditis. Kidney Int. 1983;24: 663-7.
  • Spodick DH. Pericardial diseases. Heart Disease. 6th ed. Philadelphia, London, Toronto, Montreal Sydney, Tokyo: W.B. Saunders; 2001. p. 1823.
  • Spodick DH. Acute cardiac tamponade. N Engl J Med. 2003;349:684.
  • Spodick DH. Pericardial disease in the vasculitis connective tissue disease group. The pericardium. A comprehensive textbook. New York: Marcel Dekker; 1997. p. 314-33.
  • Tarbell NJ, Thomson L, Mauch P. Thoracic irradiation in Hodgkin’s disease: disease control and long term complications. Int J Radiat Oncol Biol Phys. 1990;18:275-81.
  • Tarng DC, Huang TP. Uraemic pericarditis: a reversible inflammatory state of resistance to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant. 1997;12:1051-7.
  • Tarng DC, Huang TP. Uraemic pericarditis: a reversible inflammatory state of resistance to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant. 1997;12:1051-7.
  • Tincani A, Rebaioli CB, Taglietti M, Shoenfeld Y. Heart involvement in systemic lupus erythematosus, antiphospholipid syndrome and neonatal lupus. Rheumatology (Oxford). 2006;45Suppl4:iv8.
  • Tsang TS, Enriquez-Sarano M, Freeman WK, Barnes ME, Sinak LJ, Gersh BJ. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc. 2002;77(5):429-36.
  • Tsang TS, Seward JB, Barnes ME, Bailey KR, Sinak LJ, Urban LH. Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy. Mayo Clin Proc. 2000;75:248.
  • Vassilopoulos D, Lazaros G, Tsioufis C, Vasileiou P, Stefanadis C, Pectasides D. Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra). Int J Cardiol. 2012;160:66.
  • Voskuyl AE. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford). 2006;45Suppl4:iv4.
  • Wilkes JD, Fidias P, Vaickus L, Pérez RP. Malignancy related pericardial effusion. 127 cases from the Roswell Park Cancer Institute. Cancer. 1995;76:1377.
  • Wood JE, Mahnensmith RL. Pericarditis associated with renal failure: evolution and management. Semin Dial. 2001;14:61-6.
  • Wyplosz B, Marijon E, Dougados J, Pouchot J. Sarcoidosis: an unusual cause of acute pericarditis. Acta Cardiol. 2010;65:83.
  • Zimmerman J, Yahalom J, Bar-On H. Clinical spectrum of pericardial effusion as the presenting feature of hypothyroidism. Am Heart J. 1983;106:770-1.
Fonte de datos: Dialnet